Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the <scp>ONWARDS</scp> 1–5 trials
Efficacy and hypoglycaemia outcomes of icodec versus once-daily comparators were generally consistent among adults with T2D, regardless of kidney function.
Authors
- Alice Cheng (ORCID: https://orcid.org/0000-0003-2729-606X)
- Christian Laugesen (ORCID: https://orcid.org/0000-0001-9253-9457)
- Harpreet S. Bajaj (ORCID: https://orcid.org/0000-0002-1461-1465)
- Peter R Rossing (ORCID: https://orcid.org/0000-0002-1531-4294)
- Bharath Kumar
- Malik Benamar
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Novo Nordisk (Denmark) (DK)
- Trillium Health Centre (CA)
- LMC Diabetes & Endocrinology (Canada) (CA)
- Novo Nordisk (India) (IN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1111/dom.16231
- Citations
- 3
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- Novo Nordisk